Reference Source

Hill Pharmaceutical Co.,Ltd · 66-41 · CHINA

For Hill Pharmaceutical Co.,Ltd · 66-41 · CHINA, import alert is 66-41; import alert name is Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S; country is CHINA; product is Xiao Chai Hu Tang He Si Wu Tang Jia Jian Capsules | Aller Ease Bi Qiu Tang Jia Jian (Herbal dietary supplement) | Xiao Chai Hu Tang He Si Wu Tang Jia Jian Capsules; product code is 54 F - - 99 Herbals & Botanicals (not Teas), N.E.C. | 54 F - - 99 Herbals & Botanicals (not Teas), N.E.C. | 66 V - - 99 Miscellaneous Patent Medicines, Etc; date published is 03/24/2025; address is 128 Taoyuan West Road , Lengshuitan District , Yongzhou, Hunan CHINA, verified against its source on 2026-09-16.

Firm
Hill Pharmaceutical Co.,Ltd verified
Import alert
66-41
Import alert name
Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S.
Country
CHINA verified
Address
128 Taoyuan West Road , Lengshuitan District , Yongzhou, Hunan CHINA verified
Date published
03/24/2025 verified
Product code
54 F - - 99 Herbals & Botanicals (not Teas), N.E.C. | 54 F - - 99 Herbals & Botanicals (not Teas), N.E.C. | 66 V - - 99 Miscellaneous Patent Medicines, Etc. each item verified
Product
Xiao Chai Hu Tang He Si Wu Tang Jia Jian Capsules | Aller Ease Bi Qiu Tang Jia Jian (Herbal dietary supplement) | Xiao Chai Hu Tang He Si Wu Tang Jia Jian Capsules each item verified
FDA notes
Article appears to be subject to refusal of admission pursuant to section 801(a)(3) of the Federal Food, Drug and Cosmetic Act (the Act) in that it appears to be a new drug within the meaning of Section 201(p) of the Act without an effective new drug application (NDA) [Unapproved New Drug, Section 505(a)]. The implied disease claim noted on the firm’s labeling for the product is evidence that the product is intended for use as a drug under section 201(g)(1)(B) of the Federal Food, Drug, and Cosmetic Act. verified
Sourceaccessdata.fda.gov
Verified
Review by
DatasetFDA import alert red lists: firms subject to detention without physical examination

What the source says

Hill Pharmaceutical Co.,Ltd Date Published : 03/24/2025 128 Taoyuan West Road , Lengshuitan District , Yongzhou, Hunan CHINA 54 F - - 99 Herbals & Botanicals (not Teas), N.E.C. Date Published: 03/24/2025 Desc: Xiao Chai Hu Tang He Si Wu Tang Jia Jian Capsules 54 F - - 99 Herbals & Botanicals (not Teas), N.E.C. Date Published: 04/01/2025 Desc: Aller Ease Bi Qiu Tang Jia Jian (Herbal dietary supplement) Notes: Article appears to be subject to refusal of admission pursuant to section 801(a)(3) of the Federal Food, Drug and Cosmetic Act (the Act) in that it appears to be a new drug within the meaning of Section 201(p) of the Act without an effective new drug application (NDA) [Unapproved New Drug, Section 505(a)]. The implied disease claim noted on the firm’s labeling for the product is evidence that the product is intended for use as a drug under section 201(g)(1)(B) of the Federal Food, Drug, and Cosmetic Act. 66 V - - 99 Miscellaneous Patent Medicines, Etc. Date Published: 03/24/2025 Desc: Xiao Chai Hu Tang He Si Wu Tang Jia Jian Capsules

accessdata.fda.gov, retrieved 2026-09-15

Source

Last verified against source: . Due for re-check by . This page as Markdown · OKF bundle · full dataset as JSON.

This one changes, and we watch it.FDA import alert red lists: firms subject to detention without physical examination is re-read on a schedule and every change is dated. Subscribe: Atom feed · JSON · what has changed so far.